Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00144040 · ClinicalTrials.gov registry record · NA

Improving Antibiotic Use in Acute Care Treatment

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
1,000
Enrollment target

NCT00144040: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00144040 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00144040, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target

Study Summary

Purpose The emergence and rapid rise in antibiotic resistance among common bacteria are adversely affecting the clinical course and health care costs of community-acquired infections. Because antibiotic resistance rates are strongly correlated with antibiotic use patterns, multiple organizations have declared reductions in unnecessary antibiotic use to be critical components of efforts to combat antibiotic resistance. Among humans, the vast majority of unnecessary antibiotic prescriptions are used to treat acute respiratory tract infections (ARIs) that have a viral etiology. Although the rate of antibiotic prescribing for ARIs by office-based physicians in the US has decreased about 16% from its peak in 1997, the rate of antibiotic prescribing in acute care settings (eg, emergency departments and urgent care centers), which account for 1 in 5 ambulatory antibiotic prescriptions in the US, has shown only a modest decline (6%) during this period. Translation of lessons from intervention studies in office-based practices is needed to improve antibiotic use in acute care settings.

Interventions

  • BEHAVIORAL Physician & patient education on appropriate antibiotic use
  • PROCEDURE Rapid C-reactive protein testing to guide antibiotic treatment

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2004-02
Est. Completion 2007-07
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00144040 record still lists

NCT00144040 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).

The record links to 0 conditions, and to 2 interventions - of which Physician & patient education on appropriate antibiotic use is the first listed.

NCT00144040 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00144040 about?

NCT00144040 is a clinical study titled "Improving Antibiotic Use in Acute Care Treatment". Purpose The emergence and rapid rise in antibiotic resistance among common bacteria are adversely affecting the clinical course and health care costs of community-acquired infections. Because antibiotic resistance rates are strongly correlated with antibiotic use patterns, multiple organizations hav...

What is the current status of trial NCT00144040?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2004-02. Estimated completion is 2007-07.

What interventions are being tested in trial NCT00144040?

The interventions under investigation include: Physician & patient education on appropriate antibiotic use (BEHAVIORAL), Rapid C-reactive protein testing to guide antibiotic treatment (PROCEDURE).

Who is sponsoring clinical trial NCT00144040?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00144040's enrollment target sits among peer trials

1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00144040, the US trial registry maintained by the National Library of Medicine. NCT00144040 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.